Analysis | The Health 202: One GOP senator is urging the drug industry to make good on lowering prices

allowing drug companies to offer discounted prices directly to consumers, aiming to stop the controversial rebate practice. But those rules would apply only to Medicare drug plans and Medicaid managed-care plans.

During last week’s testimony by drug executives before the Senate Finance Committee, Chairman Chuck Grassley asked whether their companies would lower prices if the Trump rule applying to public-sector plans is ultimately implemented. they would be willing to lower prices if rebates were banned in the private sector, too.

During the hearing, Bristol-Myers Squibb chief executive Giovanni Caforio said he shared the same position. After a follow-up question, Bristol-Myers Squibb said it remains “committed to working with Congress and the Administration on reforming the rebate system with a focus on what is best for patients.”After the hearing, Sen.

"[T]he legislation appears to do absolutely nothing to address the root cause of the problem: high list prices that only the drug manufacturers have the power to set," J.C. Scott, president of the Pharmaceutical Care Management Association, told The Health 202 in a statement."Despite drug manufacturers’ rhetoric, their pricing strategies are unrelated to the rebates they negotiate with PBMs.

“This bill doesn’t outlaw PBMs. It doesn’t even outlaw rebates. What it’s going to do is shed light on the process so they’re not going to be able to get by with the argument that there’s room for a whole other layer of a middleman,” Braun said. “You don’t need it."AHH, OOF and OUCH

Key figure in this tweet: '1' Only ONE single Republican senator is actually pushing for what the GOP promised. One. Progress? 🇷🇺🐘💩

The pharmacy industry has proven , again and again, that it is a predatory monopolistic industry. Serious regulation is necessary.

Isn’t he the guy that defeated Joe Donnelly (D) last November? 😏

The GOP thinks they can just ask corporations nicely to do the right thing even though there are very few cases that ever happens

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Analysis | The Health 202: Republicans appear open to the administration's Medicare threat to the pharmaceutical industryThe Health 202: Republicans appear open to the administration's Medicare threat to the pharmaceutical industry How about repealing the law that actually makes it illegal for Medicare to negotiate with drug companies? ТЕБЕ КАЖЕТСЯ This would be better than the nothing we have now so let’s do it. Make it happen Mr President
출처: washingtonpost - 🏆 95. / 72 더 많은 것을 읽으십시오 »

Mental health app makers join forces to go after multibillion-dollar marketAbleTo, a start-up with a network of licensed therapists and coaches, acquired Joyable, the latest in a string of recent deals in mental health. It will fail, if their goal was to help the mentally ill I would have said yea but their goal is to make money
출처: CNBC - 🏆 12. / 72 더 많은 것을 읽으십시오 »

Three stocks to buy for a health-care comebackHealth-care stocks are trailing the S&P 500, but investors could find profits in some medical device plays, says stock-picking expert Matt Maley. how come those health-care companies will be survive under Democrat socialist agenda ? 😎
출처: CNBC - 🏆 12. / 72 더 많은 것을 읽으십시오 »